Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,589 | 1,904 | 2,094 | 2,226 | 2,346 |
| Marketable Securities | 794 | 972 | 1,627 | 2,161 | 2,810 |
| Other current assets | 118 | 66 | 85 | 130 | 220 |
| TOTAL | $2,501 | $2,942 | $3,806 | $4,517 | $5,376 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1 |
| Intangibles | 380 | 380 | 380 | 380 | 380 |
| TOTAL | $380 | $380 | $380 | $380 | $381 |
| Total Assets | $2,881 | $3,322 | $4,186 | $4,897 | $5,757 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 163 | 241 | 187 | 153 | 172 |
| TOTAL | $163 | $241 | $187 | $153 | $172 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 22 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $22 |
| Total Liabilities | $163 | $241 | $187 | $153 | $194 |
| Shareholders' Equity | |||||
| Common Shares | 14,120 | 14,120 | 14,120 | 14,120 | 14,120 |
| Retained earnings | -157,748 | -157,385 | -156,467 | -155,722 | -154,903 |
| Other shareholders' equity | 20 | 20 | 20 | 20 | 20 |
| TOTAL | $2,718 | $3,081 | $3,999 | $4,744 | $5,563 |
| Total Liabilities And Equity | $2,881 | $3,322 | $4,186 | $4,897 | $5,757 |